Valeant Buys Vital Science Corp.

Aliso Viejo-based Valeant Pharmaceuticals, a developer of pharmaceuticals for the neurology and dermatology markets, announced today that it has agreed to acquire Vital Science Corp., a manufacturer of over-the-counter dermatology products based in Toronto, Canada. The firm said the deal was worth approximately C$10.5M, and that Vital Science Corp. has annual sales of approximately C$11M. The firm said it expects the deal to close in the second quarter. Valeant appears to be on an acquisition roll; the firm acquired to dermatology firms in Brazil earlier this year, one in March, the other in April.